Lymphocytosis and ibrutinib treatment of CLL

被引：18

作者：

Rossi, Davide ^{[1
]}

Gaidano, Gianluca ^{[1
]}

机构：

[1] Amedeo Avogadro Univ Eastern Piedmont, Alessandria, Italy

来源：

BLOOD | 2014年 / 123卷 / 12期

关键词：

LEUKEMIA; LYMPHOMA;

D O I：

10.1182/blood-2014-01-549493

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1772 / 1774

页数：5

共 8 条

[1] Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia [J].

Byrd, John C. ;

Furman, Richard R. ;

Coutre, Steven E. ;

Flinn, Ian W. ;

Burger, Jan A. ;

Blum, Kristie A. ;

Grant, Barbara ;

Sharman, Jeff P. ;

Coleman, Morton ;

Wierda, William G. ;

Jones, Jeffrey A. ;

Zhao, Weiqiang ;

Heerema, Nyla A. ;

Johnson, Amy J. ;

Sukbuntherng, Juthamas ;

Chang, Betty Y. ;

Clow, Fong ;

Hedrick, Eric ;

Buggy, Joseph J. ;

James, Danelle F. ;

O'Brien, Susan .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (01) :32-42

[2] Novel Targeted Agents and the Need to Refine Clinical End Points in Chronic Lymphocytic Leukemia [J].

Cheson, Bruce D. ;

Byrd, John C. ;

Rai, Kanti R. ;

Kay, Neil E. ;

O'Brien, Susan M. ;

Flinn, Ian W. ;

Wiestner, Adrian ;

Kipps, Thomas J. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (23) :2820-2822

[3] The Significance of Stereotyped B-Cell Receptors in Chronic Lymphocytic Leukemia [J].

Darzentas, Nikos ;

Stamatopoulos, Kostas .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (02) :237-+

[4] Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines [J].

Hallek, Michael ;

Cheson, Bruce D. ;

Catovsky, Daniel ;

Caligaris-Cappio, Federico ;

Dighiero, Guillaume ;

Doehner, Hartmut ;

Hillmen, Peter ;

Keating, Michael J. ;

Montserrat, Emili ;

Rai, Kanti R. ;

Kipps, Thomas J. .

BLOOD, 2008, 111 (12) :5446-5456

[5] B-cell receptor signaling as a driver of lymphoma development and evolution [J].

Niemann, Carsten U. ;

Wiestner, Adrian .

SEMINARS IN CANCER BIOLOGY, 2013, 23 (06) :410-421

[6] Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial [J].

O'Brien, Susan ;

Furman, Richard R. ;

Coutre, Steven E. ;

Sharman, Jeff P. ;

Burger, Jan A. ;

Blum, Kristie A. ;

Grant, Barbara ;

Richards, Donald A. ;

Coleman, Morton ;

Wierda, William G. ;

Jones, Jeffrey A. ;

Zhao, Weiqiang ;

Heerema, Nyla A. ;

Johnson, Amy J. ;

Izumi, Raquel ;

Hamdy, Ahmed ;

Chang, Betty Y. ;

Graef, Thorsten ;

Clow, Fong ;

Buggy, Joseph J. ;

James, Danelle F. ;

Byrd, John C. .

LANCET ONCOLOGY, 2014, 15 (01) :48-58

[7] Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia [J].

Rossi, Davide ;

Rasi, Silvia ;

Spina, Valeria ;

Bruscaggin, Alessio ;

Monti, Sara ;

Ciardullo, Carmela ;

Deambrogi, Clara ;

Khiabanian, Hossein ;

Serra, Roberto ;

Bertoni, Francesco ;

Forconi, Francesco ;

Laurenti, Luca ;

Marasca, Roberto ;

Dal-Bo, Michele ;

Rossi, Francesca Maria ;

Bulian, Pietro ;

Nomdedeu, Josep ;

Del Poeta, Giovanni ;

Gattei, Valter ;

Pasqualucci, Laura ;

Rabadan, Raul ;

Foa, Robin ;

Dalla-Favera, Riccardo ;

Gaidano, Gianluca .

BLOOD, 2013, 121 (08) :1403-1412

[8] Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy [J].

Woyach, Jennifer A. ;

Smucker, Kelly ;

Smith, Lisa L. ;

Lozanski, Arletta ;

Zhong, Yiming ;

Ruppert, Amy S. ;

Lucas, David ;

Williams, Katie ;

Zhao, Weiqiang ;

Rassenti, Laura ;

Ghia, Emanuela ;

Kipps, Thomas J. ;

Mantel, Rose ;

Jones, Jeffrey ;

Flynn, Joseph ;

Maddocks, Kami ;

O'Brien, Susan ;

Furman, Richard R. ;

James, Danelle F. ;

Clow, Fong ;

Lozanski, Gerard ;

Johnson, Amy J. ;

Byrd, John C. .

BLOOD, 2014, 123 (12) :1810-1817

← 1 →